Thinking creatively about patient involvement in publications
March 7, 2023 | healthcare comms, medical publication professionals, patient involvement in medcomms
Bedrock’s freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.
The International Society for Medical Publication Professionals (ISMPP) 2023 European meeting theme was ‘Fueling Creativity’, and the various topics covered across the 2 days certainly got the Bedrock team thinking. How can we be creative in our approach to delivering compelling and impactful publications and medical communications? One clear area of focus at the meeting was patient involvement in publications, and our team have been reflecting on this and what it means for us as healthcare communication professionals.
Plain language summaries (PLS) have been a hot topic of ISMPP meetings for several years. The value of creating publication content tailored to non-specialist audiences (e.g. time-poor specialists/generalists, payers/policy makers, healthcare professionals [HCPs] with English as a second language, allied HCPs, lay audiences including patients and carers) is now widely recognised by publication professionals; it is becoming increasingly common to see a PLS developed alongside the publication of clinical trial data or as a standalone PLS (plain language summary of a publication). What remains less clear is how patient partners can be effectively engaged and involved throughout the entire end-to-end publication planning and development process.
Good Publication Practice (GPP) 2022 guidance recognises patients as experts who can provide important input into publications at various stages, including during publication planning, as authors and in the development of PLS (see figure below):1
ICMJE, International Committee of Medical Journal Editors; PLS, plain language summary; PLSP, plain language summary of a publication.
Patient involvement in end-to-end publication planning and development has the potential to add huge value through improving accessibility of clinical trial data to non-specialist audiences. However, it is clear that challenges remain and publication professionals need to adopt a more proactive, creative and agile approach to early engagement with patients in the process. Discussion during the ISMPP 2023 meeting brought up some interesting and thought-provoking topics and questions for us to consider moving forwards:
- Identifying the right patient partners is a challenge – how and where can we find patients?
- Appropriate compensation for patients’ time in supporting publication activities is permitted, though remains somewhat controversial – how should/can we navigate this?
- There are many practical things to consider when involving patients in publications to ensure optimal contribution – how can we best make adjustments to processes and timelines to accommodate this?
- Best-practice sharing will support the industry to progress in effective patient involvement in publications – how can we better collaborate and share key learning and information?
- Tools and resources exist to help advocate and coordinate patient involvement in publications and to support development of PLS – how can we raise awareness and better standardise the quality of content?
Overall, great progress has been made over recent years towards involving patients in publications and much of this has focused on PLS development, which has enabled better engagement of non-specialists in healthcare. How can we, as publication and medical communications professionals, contribute to improving patient involvement in the full end-to-end publication process?
As part of our commitment to ‘reimagining publications’, Bedrock is looking at how we can address the key challenges outlined above alongside our patient focused sister agency, Origins. Bedrock and Origins are collaborating to think creatively and compliantly about engagement of patients in the entire publication process. To talk to us about our work in publications and medical communications, and how we improve patient involvement and focus throughout the entire clinical development and lifecycle management process, please contact Louise Adamson louiseadamson@bedrock-health.com
Reference:
- DeTora LM, et al. Ann Intern Med. 2022;175(9):1298–304.
Company Details
Latest Content from Bedrock Healthcare Communications
Mergers and acquisitions: agents for change
Getting the best from your agency in a disruptive time
Bedrock Group celebrates a trio of new hires
Bedrock Group is gearing up for a year of incredible growth with the hire of two new Strategic Solutions Directors as well as an additional Account Manager.
This isn’t goodbye, it’s see you in August!
Bedrock Group imagines, creates and delivers industry-leading benefits
SIGHT project team wins top recognition award
SIGHT project team scoops the Bedrock Group CEO Team Award 2019
How 2019 ignited my passion for insights
Stacey East, Insights Manager, Origins, shares her learnings from the Pharma Market Research Conference
Meg Morgan wins top recognition award
Meg scoops the Bedrock Group’s CEO 2019 Award
Bedrock’s on fire for Wellbeing Week
Bedrock creates a positive working environment to enable individuals and our business to thrive.
Insights from non-healthcare marketing: Brand Activism – does it have a role in Pharma?
Increasingly consumers are demanding that brands be more active – that they not only stand for something, but they do something about it.
Rewarding Long Service at Bedrock
Katie Penfold celebrates 5 years with the Bedrock Group
Bedrock are in the Top 3
Bedrock named No. 3 Young Agency by PMLive